Author:
Hu Lili,Wu Na,Wang Jue,Yao Mingze,Han Bo
Funder
2022 Shanxi Province Basic Research Program Free Exploration Class
Publisher
Springer Science and Business Media LLC
Reference48 articles.
1. Sung, H., Ferlay, J., & Siegel, R. L., et al. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 71(3), 209–249.
2. Harsanyi, S., Novakova, Z. V., & Bevizova, K., et al. (2022). Biomarkers of bladder cancer: Cell-free DNA, epigenetic modifications and non-coding RNAs. International Journal of Molecular Sciences, 23(21), 13206.
3. DeGeorge, K. C., Holt, H. R. & & Hodges, S. C. (2017). Bladder cancer: Diagnosis and treatment. American Family Physician, 96, 507–514.
4. Isono, M., Okubo, K., & Asano, T., et al. (2021). Inhibition of checkpoint kinase 1 potentiates anticancer activity of gemcitabine in bladder cancer cells. Scientific Reports, 11(1), 1–8.
5. Xian, Y. F., Mao, Q. Q., & Ip, S. P., et al. (2011). Comparison on the anti-inflammatory effect of Cortex Phellodendri Chinensis and Cortex Phellodendri Amurensis in 12-O-tetradecanoyl-phorbol-13-acetate-induced ear edema in mice. Journal of Ethnopharmacology, 137(3), 1425–1430.